Join Shattuck Labs, Inc. for a data call to present the initial data from the frontline expansion cohorts in HR-MDS…
Join the Ligand Pharmaceuticals Annual Investor Day in-person or via webcast, discussing Ligand's strategy, portfolio, and financial outlook supporting the clinical development of…
Join TScan Therapeutics for a virtual KOL event, featuring Monzr M. Al Malki, MD (City of Hope) who will review the initial…
Time: 11:00 AM - 12:30 PM PST Join Galapagos for an in-person KOL event during the 65th ASH Annual Meeting…
Join Codexis for a virtual KOL event featuring John Maraganore, PhD (Founder and Former Chief Executive Officer of Alnylam Pharmaceuticals) and David Butler, PhD (Chief…
Join Lumos Pharma for a virtual KOL event featuring Andrew Dauber, M.D., M.M.Sc.,(Children’s National Hospital), Fernando Cassorla, M.D. (Institute of…
Join us for a virtual KOL event with Sol-Gel Technologies, featuring Julie Breneiser (Executive Director, Gorlin Syndrome Alliance) and Ervin Epstein Jr., MD…
Join AcelRx Pharmaceuticals (Nasdaq: ACRX) for a KOL panel discussion on the anticoagulant market for dialysis and the Niyad NEPHRO…
Join us for a virtual KOL event with Kineta, featuring immunology expert Michael A. Curran, PhD (MD Anderson Cancer Center Department…
Join Gamida Cell for a virtual fireside chat with thought leader Gary Schiller, MD, FACP, Professor of Medicine and Director of the Hematological Malignancy/Stem…
Join BiomX for a virtual KOL event, featuring Dr. Eitan Kerem, M.D. (Hadassah University Medical Center) and Dr. Robert T. “Chip” Schooley,…
Join us for a virtual KOL Event with BioAtla, featuring Carl M. Gay, MD, PhD (MD Anderson Cancer Center) who will review…
Join IDEAYA Biosciences for a virtual Investor R&D day featuring GSK and a KOL, showcasing scientific insights and clinical development…

Join Immix Biopharma and key opinion leaders Heather Landau, MD (Director of Amyloidosis Program, Memorial Sloan-Kettering Cancer Center), Vaishali Sanchorawala, MD (Professor,…
Join us for a virtual KOL event to discuss new data from the ongoing Phase 2 ReSPECT-GBM trial of rhenium…
Dr. Anthony J. Olszanski, M.D., RPh (Fox Chase Cancer Center) will join Antengene for their 2023 R&D Day. During the event, Antengene’s…